Concert Pharma (CNCE) Tops Q3 EPS by 12c

November 8, 2016 7:22 AM EST
Get Alerts CNCE Hot Sheet
Trade CNCE Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Concert Pharma (NASDAQ: CNCE) reported Q3 EPS of ($0.51), $0.12 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $26 thousand versus the consensus estimate of $420 thousand.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment